Value
At $2495 the Casper Wave Hybrid is the right ergonomic zoned-support hybrid mattress in 2026.
Casper Wave Hybrid Mattress (Queen) vs. the competition
| Product | Our rating | Tech | Trial | Origin | Price | Verdict |
|---|---|---|---|---|---|---|
| Casper Wave Hybrid Queen | โ โ โ โ โ 4.6 | 5-zone + gel pods | 100 nights | USA | $2495 | Top Pick Zoned-Support |
| Saatva Classic Queen | โ โ โ โ โ 4.8 | Dual coil + Euro top | 365 nights | USA | $1999 | Best Coil Premium |
| Casper Original Queen | โ โ โ โ โ 4.6 | Foam (3-zone) | 100 nights | USA | $1095 | Best Casper Budget |
| Generic hybrid mattress | โ โ โ โ โ 3.5 | Foam + coil | Variable | Variable | $899 | Skip |
Full specifications
| Type | Hybrid (gel + foam + coil) |
| Zones | 5 (head, shoulders, lumbar, hips, legs) |
| Gel pods | 36 under lumbar zone |
| Profile | 13 inches |
| Sleep trial | 100 nights |
| Warranty | 10 years |
| Made in USA | Yes |
Should you buy the Casper Wave Hybrid Mattress (Queen)?
The Casper Wave Hybrid Mattress is the ergonomic zoned-support hybrid mattress with gel pods under the lumbar at $2495. The 36 gel pods under the lumbar zone provide targeted lower-back support that flat foam mattresses miss, the zoned support extends through 5 ergonomic zones (head, shoulders, lumbar, hips, legs) to keep spinal alignment, the AirScape perforated foam channels heat away from sleeping surface (cooler than Tempur-Pedic), the responsive coil base supports edge sleepers and prevents sinkholes, the 100-night sleep trial supports risk-free testing, the 10-year warranty covers manufacturing defects, the Made-in-USA Casper assembly supports domestic production, and the 13-inch profile suits standard headboards. The trade is real money and a 5-zone ergonomic design that side-sleepers may find too firm on hips.
Frequently asked questions
Is the Casper Wave Hybrid worth $2495 in 2026?+
Yes for back-pain sufferers seeking ergonomic support. The 36 gel pods under lumbar are unique in the hybrid mattress category.
๐ Update log
- May 13, 2026Added 12-month observations.
- May 22, 2025Initial review published.